XELGLITA

Details for Australian Trade Mark No. 1438535 (hide)

Owner Merck Sharp & Dohme Corp. a New Jersey corporation

Service Shelston IP

Filing Date 22 July 2011

Classes

Class 5 Pharmaceutical preparations for the treatment and prevention of diabetes

Event Publications

4 August 2011 Application filed

29 March 2012 Application Accepted

5 July 2012 Subsequent Applications/Holder Recorded - Full Assignment

  Schering Corporation is the full asignee of Merck Sharp & Dohme Corp. a company organized under the laws of the State of New Jersey.

12 July 2012 Trade Mark Registered/Protected

26 July 2012 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp. a New Jersey corporation.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1438536-TESLITA

1438534-TESLITAZ